Women out-earn men in healthcare CIO role

Women are out-earning their male counterparts in the role of chief information officer in the healthcare field, according to a new salary report from the College of Healthcare Information Management Executives (CHIME).

The findings buck the national trend of men earning more than women.

Women earned almost $30,000 more than men in base salary on average, according to the report. Women averaged a salary of $257,340, while men earned $228,217, on average. About 27% of the survey respondents were women.

“In many organizations, the CIO is a strategic partner who works across the healthcare system to improve health and care,” D. Sheree McFarland, a member of the CHIME Board of Trustees and Division CIO of the West Florida Division of HCA Healthcare, said in a statement. “As a member of Women of CHIME, it is rewarding to see that gender is not a barrier to equitable pay and that both our women and men members are recognized for their contributions.”

Overall, senior healthcare IT executives were earning 13% more in 2018, with an average salary of $235,806, compared to 2012, when the average salary was $208,417. Just 3% of respondents said they were unhappy with their compensation averaging $168,857, while 16% were very satisfied with an averaged compensation of $302,731.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.